The largest community of pharma leaders

Dr George G. Zhanel Joins Devonian’s Cannabinoids Scientific Advisory Board.

QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation“) (TSXv: GSD), a clinical stage biopharmaceutical corporation focused on developing a unique portfolio of botanical prescription drugs and cosmeceutical products, today announces that Professor George G. Zhanel has joined the Corporation’s Scientific Advisory Board for its Cannabinoids-based pharmaceutical program. Dr. Zhanel received his Ph.D. in the Department of Medical Microbiology/Infectious Diseases….

Recent Articles